Inflammation & Immune Activation
IAS 2013: HIV, Inflammation, and Aging [VIDEO]
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Gregory Fowler
HIV has become a chronic disease for people who have access and respond to antiretroviral therapy, but it leads to persistent immune activation and inflammation that could cause problems as people with HIV reach their 60s, 70s, and 80s, Steven Deeks from the University of California at San Francisco said in a keynote address at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
Very Early Antiretroviral Therapy Does Not Prevent Immune Activation
- Details
- Category: Search for a Cure
- Published on Wednesday, 15 May 2013 00:00
- Written by Liz Highleyman
People who started antiretroviral therapy (ART) during acute HIV infection and experienced sustained viral suppression saw a substantial decrease in immune activation markers on their CD8 T-cells after 2 years of treatment, but often not to the level seen in HIV negative individuals, according to a report in the April 15, 2013, Journal of Acquired Immune Deficiency Syndromes.
CROI 2013: Researchers Look at Neurological Complications among People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Monday, 25 March 2013 00:00
- Written by Matt Sharp
Data from a small, yet well-designed trial to evaluate whether particular antiretroviral therapy (ART) regimens penetrate the central nervous system (CNS) and enhance neurocognitive performance were among several interesting findings regarding neurological complications among people with HIV presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta. Another study looked at similarities between Alzheimer's disease and neurocognitive impairment in people with HIV.
CROI 2013: Random Anal Biopsies Improve Detection of Pre-cancerous Lesions
- Details
- Category: HIV-Related Conditions
- Published on Wednesday, 10 April 2013 00:00
- Written by Matt Sharp
Performing random anal biopsies increases the rate of diagnosis of high-grade squamous intraepithelial lesions (HSIL) during high-resolution anoscopy, researchers from Mt. Sinai School of Medicine in New York City reported at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013).
CROI 2013: Statins for People with HIV -- How Sweet Is It?
- Details
- Category: HIV-Related Conditions
- Published on Thursday, 21 March 2013 00:00
- Written by Matt Sharp
Statins may help reduce co-morbid conditions such as cardiovascular disease and lower mortality for some people with HIV, but with a possible trade-off of higher diabetes risk, according to a series of studies presented and discussed at 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta.
More Articles...
- CROI 2013: HIV+ Men at Increased Risk for Co-morbid Conditions Regardless of Age
- CROI 2013: Can HIV Elite Controllers Benefit from Antiretroviral Treatment?
- Low-Level HIV Viral Load Linked to Gut Leakage and Inflammation
- AIDS 2012: Studies Shed Light on Inflammation and Immune Activation in People with HIV